2021-07-01
Novel and emerging mutations of SARS-CoV-2
Publication
Publication
Biomedicine and Pharmacotherapy , Volume 139
<p>Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its virulence and pathogenesis. Hence, understanding these features can be used to predict the future transmission dynamics of SARS-CoV-2 infection, drug development, and vaccine. In this review, we discuss the most recent findings on the mutations in the SARS-CoV-2, which provide valuable information on the genetic diversity of SARS-CoV-2, especially for DNA-based diagnosis, antivirals, and vaccine development for COVID-19.</p>
| Additional Metadata | |
|---|---|
| doi.org/10.1016/j.biopha.2021.111599, hdl.handle.net/1765/136057 | |
| Biomedicine and Pharmacotherapy | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Elmira Mohammadi, Fatemeh Shafiee, Kiana Shahzamani, Mohammad Mehdi Ranjbar, Abbas Alibakhshi, Shahrzad Ahangarzadeh, … Shaghayegh HaghjooyJavanmard. (2021). Novel and emerging mutations of SARS-CoV-2. Biomedicine and Pharmacotherapy (Vol. 139). doi:10.1016/j.biopha.2021.111599 |
|